Small-molecule inhibitors of GRHL transcription factors for use in cancer treatment, especially colorectal cancer
Patent inventors: Tomasz Wilanowski, Adam Jarmuła, Piotr Maj, Katarzyna Wiktorska, Anna Pogorzelska

A description of the invention will be available after the patent application is published.

Nencki Institute is the co-applicant with University of Warsaw and National Medicines Institutes. University of Warsaw is the leader in patent protection and commercialization-related activities.

For more information contact Technology Transfer Office.

Application number:
P.442297 (15.09.2022)
Patent status: